SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Latest Insider Confidence Score

2026Q1

52.4
Bullish

Company insider confidence (by quarter)

2012Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
New Enterprise Associates 11 Lp — 3,820,625 Nov 12, 2015
Khattar Jack A. CEO 1,005,600 Oct 10, 2025
Orbimed Advisors Llc 10% Owner 817,000 Feb 14, 2013
Isaly Samuel D 10% Owner 817,000 Feb 14, 2013
Orbimed Capital Gp II Llc 10% Owner 817,000 Feb 14, 2013

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 28, 2026 Mar 3, 2026 Khattar Jack A. CEO Neutral 52.5 - 0.00% ✗ -
Feb 28, 2026 Mar 3, 2026 DEC TIMOTHY C CFO Neutral 52.5 - 0.00% ✗ -
Feb 28, 2026 Mar 3, 2026 Mottola Frank SVP, Chief Tech. Ops. Officer Neutral 52.5 - 0.00% ✗ -
Feb 25, 2026 Feb 26, 2026 Mottola Frank SVP, Chief Tech. Ops. Officer Sell 86.3 +898 5.22% ✗ $49.5K
Feb 25, 2026 Feb 26, 2026 DEC TIMOTHY C CFO Sell 95.0 +1,221 31.36% ✗ $64.8K
Feb 25, 2026 Feb 26, 2026 Bhatt Padmanabh P. Sr. VP of IP, CSO Sell 83.8 +600 3.65% ✗ $32.9K
Feb 25, 2026 Feb 26, 2026 Rubin Jonathan SVP, Chief Medical Officer Sell 83.8 +575 4.50% ✗ $34.2K
Feb 24, 2026 Feb 25, 2026 DEC TIMOTHY C CFO Sell 95.0 +2,256 137.73% ✗ $120.8K
Feb 24, 2026 Feb 25, 2026 NEWHALL CHARLES W III Director Neutral 82.5 +4,475 3.74% ✗ -
Feb 24, 2026 Feb 25, 2026 Hudson Frederick M. Director Neutral 85.0 +4,475 7.30% ✗ -
Feb 24, 2026 Feb 25, 2026 Barlow Carrolee Director Neutral 90.0 +4,475 19.83% ✗ -
Feb 24, 2026 Feb 25, 2026 Bhatt Padmanabh P. Sr. VP of IP, CSO Sell 95.0 +1,544 10.36% ✗ $80.7K
Feb 24, 2026 Feb 25, 2026 Mottola Frank SVP, Chief Tech. Ops. Officer Sell 90.0 +1,484 9.44% ✗ $83.8K
Feb 24, 2026 Feb 25, 2026 Rubin Jonathan SVP, Chief Medical Officer Sell 91.3 +1,482 13.13% ✗ $49.7K
Feb 23, 2026 Feb 25, 2026 GEMAYEL GEORGES Director Neutral 90.0 +4,475 13.29% ✗ -
Feb 19, 2026 Feb 23, 2026 Sensenig Bethany Director Sell 11.3 -4,475 -100.00% ✓ $228.3K
Feb 18, 2026 Feb 20, 2026 DEC TIMOTHY C CFO Neutral 52.5 - 0.00% ✗ -
Feb 18, 2026 Feb 20, 2026 Bhatt Padmanabh P. Sr. VP of IP, CSO Neutral 52.5 - 0.00% ✗ -
Feb 18, 2026 Feb 20, 2026 Rubin Jonathan SVP, Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 18, 2026 Feb 20, 2026 Mottola Frank SVP, Chief Tech. Ops. Officer Neutral 52.5 - 0.00% ✗ -
Feb 18, 2026 Feb 20, 2026 Khattar Jack A. CEO Neutral 52.5 - 0.00% ✗ -
Feb 18, 2026 Feb 20, 2026 GEMAYEL GEORGES Director Neutral 52.5 - 0.00% ✗ -
Feb 18, 2026 Feb 20, 2026 Barlow Carrolee Director Neutral 52.5 - 0.00% ✗ -
Feb 18, 2026 Feb 20, 2026 Sensenig Bethany Director Neutral 52.5 - 0.00% ✗ -
Feb 18, 2026 Feb 20, 2026 NEWHALL CHARLES W III Director Neutral 52.5 - 0.00% ✗ -
Feb 18, 2026 Feb 20, 2026 Hudson Frederick M. Director Neutral 52.5 - 0.00% ✗ -
Jan 9, 2026 Jan 12, 2026 Hudson Frederick M. Director Neutral 52.5 - 0.00% ✗ -
Dec 19, 2025 Dec 22, 2025 Mottola Frank SVP, Chief Tech. Ops. Officer Sell 8.8 -20,000 -39.22% ✓ $1M
Dec 18, 2025 Dec 19, 2025 Bhatt Padmanabh P. Sr. VP of IP, CSO Sell 46.3 -710 -4.67% ✗ $31.6K
Nov 21, 2025 Nov 24, 2025 NEWHALL CHARLES W III Director Neutral 52.5 - 0.00% ✗ -
Nov 13, 2025 Nov 17, 2025 Bhatt Padmanabh P. Sr. VP of IP, CSO Neutral 52.5 - 0.00% ✗ -
Oct 9, 2025 Oct 10, 2025 Khattar Jack A. CEO Sell 36.3 -59,900 -2.64% ✓ $3M
Oct 9, 2025 Oct 10, 2025 NEWHALL CHARLES W III Director Sell 15.0 -25,000 -19.28% ✓ $1.3M
Oct 2, 2025 Oct 3, 2025 Khattar Jack A. CEO Sell 45.0 -15,325 -0.45% ✗ $708.2K
Oct 2, 2025 Oct 3, 2025 Khattar Jack A. CEO Sell 51.3 -1,904 -0.09% ✓ $91.5K
Oct 1, 2025 Oct 2, 2025 Khattar Jack A. CEO Sell 40.0 -40,173 -1.82% ✓ $1.9M
Sep 30, 2025 Oct 1, 2025 Khattar Jack A. CEO Sell 46.3 -8,588 -0.40% ✓ $414.4K
Sep 29, 2025 Sep 30, 2025 Khattar Jack A. CEO Sell 46.3 -10,235 -0.47% ✓ $491.5K
Sep 25, 2025 Sep 26, 2025 Rubin Jonathan SVP, Chief Medical Officer Sell 46.3 -840 -7.09% ✗ $38.8K
Sep 23, 2025 Sep 24, 2025 Khattar Jack A. CEO Sell 40.0 -29,513 -1.36% ✓ $1.4M
Sep 22, 2025 Sep 23, 2025 Khattar Jack A. CEO Sell 45.0 -16,587 -0.77% ✓ $779.9K
Sep 12, 2025 Sep 15, 2025 Mottola Frank SVP, Chief Tech. Ops. Officer Sell 22.5 -5,000 -24.40% ✗ $229.4K
Sep 10, 2025 Sep 12, 2025 Rubin Jonathan SVP, Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Sep 10, 2025 Sep 12, 2025 Khattar Jack A. CEO Neutral 52.5 - 0.00% ✗ -
Sep 8, 2025 Sep 9, 2025 Khattar Jack A. CEO Sell 45.0 -6,322 -0.57% ✓ $292.6K
Sep 5, 2025 Sep 8, 2025 Khattar Jack A. CEO Sell 36.3 -55,578 -2.56% ✓ $2.6M
Aug 27, 2025 Aug 29, 2025 Khattar Jack A. CEO Sell 40.0 -34,800 -1.08% ✓ $1.6M
Aug 27, 2025 Aug 29, 2025 NEWHALL CHARLES W III Director Sell 41.3 -3,588 -2.69% ✓ $161.5K
Aug 25, 2025 Aug 27, 2025 Bhatt Padmanabh P. Sr. VP of IP, CSO Sell 46.3 -581 -4.06% ✗ $24.1K
Aug 25, 2025 Aug 27, 2025 Mottola Frank SVP, Quality, GMP, Ops, IT Sell 20.0 -14,000 -47.46% ✗ $623.1K
Aug 25, 2025 Aug 27, 2025 NEWHALL CHARLES W III Director Sell 51.3 -1,000 -0.74% ✓ $45K
Aug 25, 2025 Aug 27, 2025 Khattar Jack A. CEO Sell 57.5 -1,000 -0.05% ✓ $45K
Aug 22, 2025 Aug 26, 2025 NEWHALL CHARLES W III Director Sell 45.0 -1,412 -1.04% ✓ $63.5K
Aug 22, 2025 Aug 26, 2025 DEC TIMOTHY C CFO Sell 20.0 -11,780 -90.43% ✗ $524.1K
Aug 22, 2025 Aug 26, 2025 Khattar Jack A. CEO Sell 51.3 -1,500 -0.07% ✓ $67.5K
Aug 14, 2025 Aug 18, 2025 Sensenig Bethany Director Sell 10.0 -5,369 -100.00% ✓ $226.8K
Aug 14, 2025 Aug 18, 2025 Hudson Frederick M. Director Sell 20.0 -7,457 -13.87% ✗ $315.1K
Aug 7, 2025 Aug 8, 2025 Bhatt Padmanabh P. Sr. VP of IP, CSO Neutral 52.5 - 0.00% ✗ -
Aug 6, 2025 Aug 8, 2025 Khattar Jack A. CEO Sell 31.3 -140,000 -3.26% ✓ $5.9M
Apr 2, 2025 Apr 3, 2025 Khattar Jack A. CEO Neutral 52.5 - 0.00% ✗ -
Mar 10, 2025 Mar 11, 2025 Khattar Jack A. CEO Sell 42.5 -16,805 -0.83% ✗ $538.8K
Mar 10, 2025 Mar 11, 2025 DEC TIMOTHY C CFO Sell 42.5 -2,017 -7.60% ✗ $64.7K
Mar 7, 2025 Mar 7, 2025 Khattar Jack A. CEO Sell 42.5 -18,581 -0.92% ✗ $726.7K
Mar 7, 2025 Mar 7, 2025 Mottola Frank SVP, Quality, GMP, Ops, IT Sell 42.5 -1,356 -8.21% ✗ $53K
Mar 5, 2025 Mar 5, 2025 DEC TIMOTHY C CFO Sell 42.5 -3,193 -22.66% ✗ $105.5K
Mar 5, 2025 Mar 5, 2025 Bhatt Padmanabh P. Sr. VP of IP, CSO Sell 46.3 -1,485 -10.47% ✗ $49.1K
Mar 5, 2025 Mar 5, 2025 Mottola Frank SVP, Quality, GMP, Ops, IT Sell 42.5 -1,892 -11.99% ✗ $62.5K
Mar 5, 2025 Mar 5, 2025 Rubin Jonathan SVP, Chief Medical Officer Sell 46.3 -1,468 -13.22% ✗ $48.5K
Feb 28, 2025 Mar 4, 2025 Khattar Jack A. CEO Neutral 52.5 - 0.00% ✗ -
Feb 28, 2025 Mar 4, 2025 DEC TIMOTHY C CFO Neutral 52.5 - 0.00% ✗ -
Feb 26, 2025 Feb 26, 2025 Mottola Frank SVP, Quality, GMP, Ops, IT Sell 42.5 -2,885 -8.85% ✗ $113.9K
Feb 21, 2025 Feb 24, 2025 Bhatt Padmanabh P. Sr. VP of IP, CSO Sell 91.3 +2,390 20.26% ✗ $33.7K
Feb 21, 2025 Feb 24, 2025 Rubin Jonathan SVP, Chief Medical Officer Sell 91.3 +2,323 26.46% ✗ $36.3K
Feb 21, 2025 Feb 24, 2025 Mottola Frank SVP, Quality, GMP, Ops, IT Sell 91.3 +3,323 34.70% ✗ $21.6K
Feb 22, 2025 Feb 24, 2025 DEC TIMOTHY C CFO Neutral 90.0 +6,000 74.16% ✗ -
Feb 22, 2025 Feb 24, 2025 Hudson Frederick M. Director Neutral 90.0 +5,369 11.09% ✗ -
Feb 22, 2025 Feb 24, 2025 NEWHALL CHARLES W III Director Neutral 82.5 +5,369 4.12% ✗ -
Feb 22, 2025 Feb 24, 2025 GEMAYEL GEORGES Director Neutral 90.0 +5,369 40.32% ✗ -
Feb 22, 2025 Feb 24, 2025 Barlow Carrolee Director Neutral 90.0 +5,369 31.21% ✗ -
Feb 22, 2025 Feb 24, 2025 Sensenig Bethany Director Neutral 90.0 +5,369 100.00% ✗ -
Feb 19, 2025 Feb 21, 2025 Mottola Frank SVP, Quality, GMP, Ops, IT Neutral 52.5 - 0.00% ✗ -
Feb 19, 2025 Feb 21, 2025 Hudson Frederick M. Director Neutral 52.5 - 0.00% ✗ -
Feb 19, 2025 Feb 21, 2025 NEWHALL CHARLES W III Director Neutral 52.5 - 0.00% ✗ -
Feb 19, 2025 Feb 21, 2025 GEMAYEL GEORGES Director Neutral 52.5 - 0.00% ✗ -
Feb 19, 2025 Feb 21, 2025 Sensenig Bethany Director Neutral 52.5 - 0.00% ✗ -
Feb 19, 2025 Feb 21, 2025 Barlow Carrolee Director Neutral 52.5 - 0.00% ✗ -
Feb 19, 2025 Feb 21, 2025 Bhatt Padmanabh P. Sr. VP of IP, CSO Neutral 52.5 - 0.00% ✗ -
Feb 19, 2025 Feb 21, 2025 Rubin Jonathan SVP, Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 19, 2025 Feb 21, 2025 DEC TIMOTHY C CFO Neutral 52.5 - 0.00% ✗ -
Feb 20, 2025 Feb 21, 2025 Khattar Jack A. CEO Neutral 52.5 - 0.00% ✗ -
Feb 17, 2025 Feb 19, 2025 Khattar Jack A. CEO Neutral 52.5 - 0.00% ✗ -
Feb 17, 2025 Feb 19, 2025 Mottola Frank SVP, Quality, GMP, Ops, IT Neutral 52.5 - 0.00% ✗ -
Feb 5, 2025 Feb 6, 2025 Mottola Frank SVP, Quality, GMP, Ops, IT Neutral 52.5 - 0.00% ✗ -
Feb 4, 2025 Feb 5, 2025 Bhatt Padmanabh P. Sr. VP of IP, CSO Sell 20.0 -9,477 -48.29% ✗ $376.2K
Jan 28, 2025 Feb 5, 2025 Bhatt Padmanabh P. Sr. VP of IP, CSO Neutral 52.5 - 0.00% ✗ -
Jan 27, 2025 Jan 29, 2025 Bhatt Padmanabh P. Sr. VP of IP, CSO Sell 22.5 -3,273 -13.89% ✗ $129.7K
Jan 28, 2025 Jan 29, 2025 Rubin Jonathan SVP, Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 28, 2025 Jan 29, 2025 Mottola Frank SVP, Quality, GMP, Ops, IT Neutral 52.5 - 0.00% ✗ -
Jan 22, 2025 Jan 23, 2025 Hudson Frederick M. Director Neutral 52.5 - 0.00% ✗ -
Dec 27, 2024 Dec 30, 2024 Rubin Jonathan SVP, Chief Medical Officer Sell 46.3 -1,102 -8.32% ✗ $39.2K